Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Current pharmaceutical biotechnology, 2023, Vol.24 (1), p.23-49
2023
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Antipyretic Medicinal Plants, Phytocompounds, and Green Nanoparticles: An Updated Review
Ist Teil von
  • Current pharmaceutical biotechnology, 2023, Vol.24 (1), p.23-49
Ort / Verlag
Netherlands
Erscheinungsjahr
2023
Quelle
MEDLINE
Beschreibungen/Notizen
  • Pyrexia itself is not a terminal condition. Basically, it occurs with mild to serious diseases affecting alarge population of the world. Other than a high body temperature, pyrexia is accompanied by several sickness behaviors, changes in physiological and metabolic characteristics of the body system, and alterations in the immune responses. Various allopathic drugs are available to treat pyrexia by targeting the symptom or the pathogen itself. Drug-resistance has made control and treatment of vectors more difficult. However, many marginal people are obligated to utilize locally available medicinal plants for the treatment of various diseases due to limited access to synthetic drugs. Developments in the field of nanotechnology and phytochemical research towards the discovery of new antimicrobial agents have also drawn the interest of researchers towards the synthesis of green nanoparticles from plant extracts due to their several benefits over the other methods. Thus, the present report discusses the use of ethnomedicinal plants, phytocompounds, and the application of green nanoparticles synthesized from plant extracts to treat pyrexia.
Sprache
Englisch
Identifikatoren
ISSN: 1389-2010
eISSN: 1873-4316
DOI: 10.2174/1389201023666220330005020
Titel-ID: cdi_pubmed_primary_35352658

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX